Published in Br J Cancer Suppl on April 01, 1980
Chemotherapy of human breast-carcinoma xenografts. Br J Cancer (1980) 1.15
Human tumour xenografts: a critical appraisal. Br J Cancer Suppl (1980) 1.08
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. Br J Cancer (1980) 1.05
Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts. Br J Cancer (1984) 0.95
Growth of human bronchial carcinomas in nude mice. Br J Cancer (1985) 0.93
Human tumour xenografts growing in immunodeficient mice: a useful model for assessing chemotherapeutic agents in bronchial carcinoma. Thorax (1986) 0.92
Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck. Br J Cancer (1989) 0.85
Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients. J Clin Pathol (1981) 0.82
Limitations of the human tumour xenograft system in individual patient drug sensitivity testing. Br J Cancer (1984) 0.80
Clonogenic cell survival in cryopreserved human tumour cells. Br J Cancer (1981) 0.80
Failure of high doses of alpha interferon to affect the growth of human carcinoma, melanoma, and myeloid leukaemia xenografts. Br J Cancer (1983) 0.78
Activity of a new nitrosourea (TCNU) in human lung cancer xenografts. Br J Cancer (1988) 0.78
Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer. Br J Cancer (1985) 0.75
Studying lung cancer in the laboratory: 1--Development of model systems. Thorax (1987) 0.75
Studying lung cancer in the laboratory--2: Chemosensitivity testing. Thorax (1987) 0.75
Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep (1966) 8.79
Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer (1978) 4.28
The growth and therapeutic response of human tumours in immune deficient mice. Bull Cancer (1978) 1.69
Who's afraid of informed consent? BMJ (1993) 4.81
Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer (1978) 4.28
The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res (1975) 3.50
Combined management of malignant teratoma of the testis. Lancet (1979) 3.12
Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res (1975) 3.04
Analysis of the cell population kinetics of transplanted tumours of widely-differing growth rate. Br J Cancer (1966) 2.88
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
A prognostic model for ovarian cancer. Br J Cancer (2001) 2.77
The growth kinetics of xenografts of human colorectal tumours in immune deprived mice. Br J Cancer (1975) 2.71
Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys (1979) 2.63
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Cell proliferation studies in the intestinal epithelium of the rat. I. Determination of the kinetic parameters. Exp Cell Res (1965) 2.50
Cell loss as a factor in the growth rate of human tumours. Eur J Cancer (1967) 2.41
Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40
Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut (2004) 2.33
Malignant melanoma in Scotland 1979-1983. Lancet (1985) 2.30
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. Clin Oncol (R Coll Radiol) (1995) 1.82
Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80
In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical considerations. Eur J Cancer (1965) 1.79
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer (1978) 1.77
The growth and therapeutic response of human tumours in immune deficient mice. Bull Cancer (1978) 1.69
Cell proliferation studies in the intestinal epithelium of the rat. II. Theoretical aspects. Exp Cell Res (1965) 1.68
The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol (1984) 1.68
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
A comparison of methods for calculating DNA double-strand break induction frequency in mammalian cells by pulsed-field gel electrophoresis. Int J Radiat Biol (1994) 1.61
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58
The water soluble contrast enema after rectal anastomosis. Br J Surg (1982) 1.58
The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer (1983) 1.53
Sigmoidoscopy with a view. Br J Surg (1994) 1.51
The technique of labelled mitoses: analysis by automatic curve-fitting. Cell Tissue Kinet (1971) 1.51
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. Br J Cancer (1977) 1.51
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer (1996) 1.51
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. Ann Oncol (2008) 1.50
An evaluation of colorectal endoscopic mucosal resection using high-magnification chromoscopic colonoscopy: a prospective study of 1000 colonoscopies. Endoscopy (2004) 1.49
The growth rate of human tumours. Br J Cancer (1966) 1.49
Current surgical practice in screening for colorectal cancer based on family history criteria. Br J Surg (1998) 1.49
Small-cell lung cancer after retinoblastoma. Lancet (1989) 1.48
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer (1987) 1.47
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer (1977) 1.43
Facial paralysis due to a benign parotid tumour. Br J Surg (1989) 1.42
Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol (1976) 1.41
A human tumour model. Lancet (1986) 1.39
Quantitative techniques for study of the anatomy and function of small blood vessels in tumors. J Natl Cancer Inst (1969) 1.39
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39
A proposal for the annotation of recurrent colorectal cancer: the 'Sheffield classification'. Colorectal Dis (2011) 1.39
Breast screening and the surgeon. Br J Hosp Med (1991) 1.39
A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res (2000) 1.39
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
The cell cycle in tumours: an examination of data gained by the technique of labelled mitoses. Cell Tissue Kinet (1972) 1.34
Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33
Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer (1980) 1.31
Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br J Cancer (1979) 1.31
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. Br J Cancer (1979) 1.30
Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J (Clin Res Ed) (1985) 1.29
Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer (1992) 1.29
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29
Growth kinetics of human large bowel cancer growing in immune-deprived mice and some chemotherapeutic observations. Cancer (1975) 1.28
The role of computed tomography in the management of testicular teratoma. Clin Radiol (1979) 1.28
The impact of chemotherapy on small cell carcinoma of the bronchus. Q J Med (1986) 1.26
Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer (1984) 1.25
Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer (1985) 1.24
Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer (1977) 1.24
Influence of tumour size on radiosensitization by misonidazole. Br J Cancer Suppl (1978) 1.24
Testicular tumours. Clin Endocrinol Metab (1975) 1.20
Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer (1980) 1.20
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer (1979) 1.19
Adenosine deaminase activity in leukaemia. Br J Cancer (1975) 1.19
Chemotherapy for ovarian cancer--a consensus statement on standard practice. Br J Cancer (1998) 1.19
DNA topoisomerase I and II as targets for rational design of new anticancer drugs. Ann Oncol (1993) 1.19
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer (1973) 1.17
Colonic carcinoma presenting as strangulated inguinal hernia: report of two cases and review of the literature. Tech Coloproctol (2008) 1.16
Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe? Ann Oncol (2013) 1.16
Tumor size dependency in the radiation response of the Lewis lung carcinoma. Cancer Res (1975) 1.16
Children fathered by men treated for testicular cancer. Lancet (1985) 1.16
Delayed uptake by tumours of tritium from thymidine. Nature (1966) 1.16
Etoposide as a single agent in relapsed advanced lymphomas. A phase II study. Cancer Chemother Pharmacol (1982) 1.15
Chemotherapy of human breast-carcinoma xenografts. Br J Cancer (1980) 1.15
Anorectal function after restorative proctocolectomy and low anterior resection with coloanal anastomosis. Br J Surg (1994) 1.15
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol (1989) 1.14
Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14